Ben Johnson

10PUBLICATIONS
33CO-AUTHORS
Major global burdens of diseaseHaematological tumoursToxicology (incl. clinical toxicology)Medical physicsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Sep 23, 2026
Real-World Effectiveness of Burosumab Versus Oral Phosphate and Active Vitamin D in Adults with X-Linked Hypophosphatemia (XLH): A 3-Year Follow-Up of the XLH Disease Monitoring Program.

|Aug 11, 2026
Real-world outcomes in patients with tumor-induced osteomalacia treated vs not treated with burosumab.

|Aug 10, 2026
Burden of Disease in Pediatric Tumor-Induced Osteomalacia: A Literature Review.

|Apr 29, 2026
Pain medication use in patients with X-linked hypophosphatemia treated with burosumab: a retrospective real-world study.

|Apr 04, 2026
Real-world effectiveness of burosumab across age groups: X-linked hypophosphatemia (XLH) Disease Monitoring Program.

Leanne M Ward, Thomas O Carpenter, Hamilton Cassinelli

|Nov 04, 2025
Delayed diagnosis of X-linked hypophosphatemia in the absence of family history: a global unmet need.

Suma Uday, M Zulf Mughal, Hamilton Cassinelli

Pageof 2

Frequent Collaborators

5 joint publications

Thomas O Carpenter

5 joint publications

Zhiyi Li

4 joint publications

Erik A Imel

4 joint publications

Leanne Ward